QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.106.112631v1 320/3/978    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Naud, J. Articles by Pichette, V. Search for Related Content PubMed PubMed Citation Articles by Naud, J. Articles by Pichette, V.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats

Service de Néphrologie et Centre de Recherche Guy-Bernier, Hôpital Maisonneuve-Rosemont (J.N., J.M., C.B., K.D., F.A.L., A.B., V.P.) and Département de Pharmacologie (J.N., J.M., C.B., V.P.), Facultéde Médecine, Université de Montréal, Montreal, Quebec, Canada; Service de Pathologie, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada (A.M.); and Département d'Anatomie et de Biologie Cellulaire, Université de Sherbrooke, Sherbrooke, Quebec, Canada (C.J.)

Chronic renal failure (CRF) is associated with an increased bioavailability of drugs by a poorly understood mechanism. One hypothesis is a reduction in the elimination of drugs by the intestine, i.e., drug elimination mediated by protein membrane transporters such as P-glycoprotein (Pgp) and multidrug-resistance-related protein (MRP) 2. The present study aimed to investigate the repercussions of CRF on intestinal transporters involved in drug absorption [organic anion-transportingpolypeptide (Oatp)] and those implicated in drug extrusion (Pgp and MRP2). Pgp, MRP2, MRP3, Oatp2, and Oatp3 protein expression and Pgp, MRP2, and Oatp3 mRNA expression were assessed in the intestine of CRF (induced by five-sixth nephrectomy) and control rats. Pgp and MRP2 activities were measured using the everted gut technique. Rat enterocytes and Caco-2 cells were incubated with sera from control and CRF rats to characterize the mechanism of transporters' down-regulation. Protein expression of Pgp, MRP2, and MRP3 were reduced by more than 40% (p < 0.01) in CRF rats, whereas Oatp2 and Oatp3 expression remained unchanged. There was no difference in the mRNA levels assessed by real-time polymerase chain reaction. Pgp and MRP2 activities were decreased by 30 and 25%, respectively, in CRF rats compared with control (p < 0.05). Uremic sera induced a reduction in protein expression and in activity of drug transporters compared with control sera. Our results demonstrate that CRF in rats is associated with a decrease in intestinal Pgp and MRP2 protein expression and function secondarily to serum uremic factors. This reduction could explain the increased bioavailability of drugs in CRF.

Address correspondence to: Dr. Vincent Pichette, Centre de Recherche Guy-Bernier, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montreal, Quebec, Canada H1T 2M4. E-mail: vpichette.hmr{at}ssss.gouv.qc.ca

This article has been cited by other articles:

				T. Nakano, S. Sekine, K. Ito, and T. Horie Correlation between Apical Localization of Abcc2/Mrp2 and Phosphorylation Status of Ezrin in Rat Intestine Drug Metab. Dispos., July 1, 2009; 37(7): 1521 - 1527. [Abstract] [Full Text] [PDF]

				E. Simard, J. Naud, J. Michaud, F. A. Leblond, A. Bonnardeaux, C. Guillemette, E. Sim, and V. Pichette Downregulation of Hepatic Acetylation of Drugs in Chronic Renal Failure J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1352 - 1359. [Full Text] [PDF]

				V. E. Tovell and J. Sanderson Distinct P2Y Receptor Subtypes Regulate Calcium Signaling in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 350 - 357. [Abstract] [Full Text] [PDF]

				H. Lu and C. Klaassen Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats Drug Metab. Dispos., January 1, 2008; 36(1): 16 - 23. [Abstract] [Full Text] [PDF]

				J. Naud, J. Michaud, F. A. Leblond, S. Lefrancois, A. Bonnardeaux, and V. Pichette Effects of Chronic Renal Failure on Liver Drug Transporters Drug Metab. Dispos., January 1, 2008; 36(1): 124 - 128. [Abstract] [Full Text] [PDF]

				V. Petrovic, S. Teng, and M. Piquette-Miller REGULATION OF DRUG TRANSPORTERS: DURING INFECTION AND INFLAMMATION Mol. Interv., April 1, 2007; 7(2): 99 - 111. [Abstract] [Full Text] [PDF]